These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 17084051

  • 1. Current perspectives in dissolution testing of conventional and novel dosage forms.
    Azarmi S, Roa W, Löbenberg R.
    Int J Pharm; 2007 Jan 02; 328(1):12-21. PubMed ID: 17084051
    [Abstract] [Full Text] [Related]

  • 2. A mini review of scientific and pharmacopeial requirements for the disintegration test.
    Donauer N, Löbenberg R.
    Int J Pharm; 2007 Dec 10; 345(1-2):2-8. PubMed ID: 17935916
    [Abstract] [Full Text] [Related]

  • 3. Regulatory aspects of modified release dosage forms: special cases of dissolution testing using the flow-through system.
    Möller H, Wirbitzki E.
    Boll Chim Farm; 1993 Apr 10; 132(4):105-15. PubMed ID: 8333916
    [Abstract] [Full Text] [Related]

  • 4. Commentary on AAPS Workshop: dissolution testing for the twenty-first century: linking critical quality attributes and critical process parameters to clinically relevant dissolution.
    Tong C, D'Souza SS, Parker JE, Mirza T.
    Pharm Res; 2007 Sep 10; 24(9):1603-7. PubMed ID: 17385013
    [Abstract] [Full Text] [Related]

  • 5. Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets.
    Breier AR, Paim CS, Steppe M, Schapoval EE.
    J Pharm Pharm Sci; 2005 Aug 11; 8(2):289-98. PubMed ID: 16124939
    [Abstract] [Full Text] [Related]

  • 6. Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.
    Strauch S, Jantratid E, Dressman JB.
    J Pharm Pharmacol; 2009 Mar 11; 61(3):331-7. PubMed ID: 19222905
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the dissolution behaviour of some commercial herbal drugs and their preparations.
    Taglioli V, Bilia AR, Ghiara C, Mazzi G, Mercati V, Vincieri FF.
    Pharmazie; 2001 Nov 11; 56(11):868-70. PubMed ID: 11817172
    [Abstract] [Full Text] [Related]

  • 8. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms.
    Goole J, Vanderbist F, Amighi K.
    Int J Pharm; 2007 Apr 04; 334(1-2):35-41. PubMed ID: 17097841
    [Abstract] [Full Text] [Related]

  • 9. Effect of processing technique of different dosage forms on dissolution rate of caffeine and salicylamide.
    Nerlo H, Czarnecki W, Dul R.
    Pol J Pharmacol Pharm; 1976 Apr 04; 28(4):361-7. PubMed ID: 981026
    [Abstract] [Full Text] [Related]

  • 10. In-Vitro Drug Dissolution Studies in Medicinal Compounds.
    Bozal-Palabiyik B, Uslu B, Ozkan Y, Ozkan SA.
    Curr Med Chem; 2018 Apr 04; 25(33):4020-4036. PubMed ID: 29577852
    [Abstract] [Full Text] [Related]

  • 11. Probability of passing dissolution acceptance criteria for an immediate release tablet.
    Dumont ML, Berry MR, Nickerson B.
    J Pharm Biomed Anal; 2007 May 09; 44(1):79-84. PubMed ID: 17379465
    [Abstract] [Full Text] [Related]

  • 12. Chemical imaging of oral solid dosage forms and changes upon dissolution using coherent anti-Stokes Raman scattering microscopy.
    Windbergs M, Jurna M, Offerhaus HL, Herek JL, Kleinebudde P, Strachan CJ.
    Anal Chem; 2009 Mar 15; 81(6):2085-91. PubMed ID: 19209888
    [Abstract] [Full Text] [Related]

  • 13. Biopharmaceutical implications of compaction and consolidation in the design of drug dosage forms.
    Rees JE.
    Boll Chim Farm; 1978 Jul 15; 117(7):375-90. PubMed ID: 743383
    [No Abstract] [Full Text] [Related]

  • 14. [Natural biopolymers as excipients in medicinal product dosage form. Part I. Soft gelatin capsules as a modern and elegant pharmaceutical dosage form].
    Dobrzyński ŁJ, Zgoda MM.
    Polim Med; 2010 Jul 15; 40(2):11-9. PubMed ID: 20649085
    [Abstract] [Full Text] [Related]

  • 15. Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus.
    Garbacz G, Cadé D, Benameur H, Weitschies W.
    Eur J Pharm Sci; 2014 Jun 16; 57():264-72. PubMed ID: 24021609
    [Abstract] [Full Text] [Related]

  • 16. Dosage form design and development.
    Allen LV.
    Clin Ther; 2008 Nov 16; 30(11):2102-11. PubMed ID: 19108798
    [Abstract] [Full Text] [Related]

  • 17. Alternative Manufacturing Concepts for Solid Oral Dosage Forms From Drug Nanosuspensions Using Fluid Dispensing and Forced Drying Technology.
    Bonhoeffer B, Kwade A, Juhnke M.
    J Pharm Sci; 2018 Mar 16; 107(3):909-921. PubMed ID: 29154900
    [Abstract] [Full Text] [Related]

  • 18. Dissolution evaluation of marketed tetracyclines solid oral dosage forms.
    Yamamoto CH, Pinto Tde J, Alves MS.
    Boll Chim Farm; 2000 Mar 16; 139(2):81-4. PubMed ID: 10920533
    [Abstract] [Full Text] [Related]

  • 19. Powder for reconstitution of the anti-HIV-1 drug TMC278 - Formulation development, stability and animal studies.
    Van Gyseghem E, Pendela M, Baert L, Rosier J, Van 't Klooster G, De Man H, Bouche MP, Schueller L, Van Remoortere P, Wigerinck P, Adams E, Hoogmartens J, Van den Mooter G.
    Eur J Pharm Biopharm; 2008 Nov 16; 70(3):853-60. PubMed ID: 18657611
    [Abstract] [Full Text] [Related]

  • 20. The influence of polymorphism on the manufacturability and in vitro dissolution of sulindac-containing hard gelatin capsules.
    Guadalupe Sánchez-González E, Yépez-Mulia L, Jesús Hernández-Abad V, Jung Cook H.
    Pharm Dev Technol; 2015 May 16; 20(3):306-13. PubMed ID: 24417644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.